Our results demonstrated that miR-155 and miR-146a were up-regulated in the DN patient and experimental animal models and served as a mediator of the glucose-induced TNF-α/TGF-β1-NF-κB pathway. The gene discussed is NFKB1; the disease is liver dysplastic nodule.